A new vaccine that trains the immune system to recognize and attack cervical cancer tumours shows promise in becoming a crucial aid in fighting the disease, complementing the HPV jab that has already reduced cases by almost 90 percent in England since 2008.
This article, images and content belong to the source and curated for informational purposes.
